Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for pain prevention during Qutenza application
2012-002947-74Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aspirin and capsaicin in pain (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Mean pain intensity during and after Qutenza application and Mean visual analogue or numerical rating scale summary across scheduled post-dose timepoints. Started Jun 2013; status: completed.
02
Drugs
aspirincapsaicin
03
Conditions
pain
Beyond the preview
Go deeper on 2012-002947-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002947-74.